Ambu ROE 2022-2024 | AMBBY

Current and historical return on equity (ROE) values for Ambu (AMBBY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Ambu ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-06-30 $0.06B $0.83B 8.00%
2024-03-31 $0.05B $0.82B 6.63%
2023-12-31 $0.03B $0.78B 4.30%
2023-09-30 $0.02B $0.77B 3.22%
2023-06-30 $-0.01B $0.77B -1.18%
2023-03-31 $-0.01B $0.75B -1.73%
2022-12-31 $0.01B $0.57B 2.14%
2022-09-30 $0.01B $0.62B 2.11%
Sector Industry Market Cap Revenue
Medical Medical - Hospitals $3.966B $0.784B
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics and rescue services. It provides anaesthesia, and patient monitoring and diagnostics products. Ambu A/S is based in Ballerup, Denmark.
Stock Name Country Market Cap PE Ratio
HCA Healthcare (HCA) United States $88.788B 16.07
Tenet Healthcare (THC) United States $15.616B 14.74
Universal Health Services (UHS) United States $13.692B 13.82
Acadia Healthcare (ACHC) United States $3.726B 11.43
Community Health Systems (CYH) United States $0.586B 0.00